MYB and ovarian cancer: Additionally, we illustrated that MSCs secreted miR-424-containing EVs, which suppressed the proliferation, migration, and tube formation of HUVECs via MYB inhibition and ultimately, attenuated the tumorigenesis and angiogenesis of ovarian cancer (Fig. 7).